Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

New England Journal of Medicine

Volumn 334, Issue 5, 1996, Pages 281-285

  Goulmy, Els ^a   Schipper, Ronald ^a   Pool, Jos ^a   Blokland, Els ^a   Falkenburg, J H Frederik ^a   Vossen, Jaak ^a   Gratwohl, Alois ^b   Vogelsang, Georgia B ^c   Van Houwelingen, Hans C ^a   Van Rood, Jon J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; PREDNISOLONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DONOR; GRAFT VERSUS HOST REACTION; HISTOINCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE CLONE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIBLING;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; H-Y ANTIGEN; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HUMANS; LEUKOCYTES; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 13344278000     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199602013340501     Document Type: Article

References (28)

1. Bortin MM, Horowitz MM, Mrsic M, Rimm AA, Sobocinski KA. Progress in bone marrow transplantation for leukemia: a preliminary report from the Advisory Committee of the International Bone Marrow Transplant Registry. Transplant Proc 1991;23:61-2.
2. Martin PJ. Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantations from unrelated donors compared with related donors. Bone Marrow Transplant 1991;8:217-23.
3. Beatty PG, Hervé P. Immunogenetic factors relevant to acute graft-versus-host disease. In: Burakoff SJ, Deeg HJ, Ferrara S, Atkinson K, eds. Graft-versus-host disease: immunology, pathophysiology and treatment. Vol. 12 New York: Marcel Dekker, 1990:415-23.
4. Tsoi M-S, Storb R, Dobbs S, Medill L, Thomas ED. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease. J Immunol 1980;125:2258-62.
5. Goulmy E, Gratama J-W, Blokland E, Zwaan FE, van Rood JJ. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983;302:159-61.
6. Tsoi M-S, Storb R, Santos E, Thomas ED Anti-host cytotoxic cells in patients with acute graft-versus-host disease after HLA-identical marrow grafting Transplant Proc 1983;15:1484-6.
7. Irlé C, Beatty PG, Mickelson E, Thomas ED, Hansen JA. Alloreactive T cell responses between HLA-identical siblings: detection of anti-minor histocompatibility T cell clones induced in vivo. Transplantation 1985;40:329-33.
8. van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. I Absence of correlation with cytotoxic effector cells. Transplantation 1990;50:62-6.
9. Irschick EU, Hladik T, Niederwieser D, et al. Studies on the mechanism of tolerance of graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies. Blood 1992;79:1622-8.
10. Niederwieser D, Grassegger A, Aubock J, et al. Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 1993;81:2200-8.
11. van Els C, D'Amaro J, Pool J, et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992;35:161-5.
12. Schreuder GMT, Pool J, Blokland E, et al A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA. Immunogenetics 1993;38:98-105
13. Storb R, Deeg HJ, Whitehead J, et al Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia N Engl J Med 1986;314: 729-35.
14. Goulmy E. Minor histocompatibility antigens and their role in transplantation. In: Morris PJ, Tilney NL, eds. Transplant reviews Vol. 2. Philadelphia: W.B. Saunders, 1988:29-54.
15. Idem. HLA-A, -B restriction of cytotoxic T cells. In: Ferrone S, Solheim BG, eds. HLA typing methodology and clinical aspects. Vol 2. New York: CRC Press, 1982:105-22.
16. Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med 1975;292:832-43, 895-902.
17. Armitage JO. Bone marrow transplantation. N Engl J Med 1994,330:827-38.
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no 32)
19. Zelen M. The analysis of several 2×2 contingency tables. Biometrika 1971; 58:129-37.
20. Elkins WL, Pierson GR, Storb R Study of a human minor alloantigen in relation to clinical graft-versus-host disease Bone Marrow Transplant 1987; 1:397-403.
21. de Bueger M, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibilily antigens ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992,149:1788-94.
22. van Lochem E, van der Keur M, Mommaas AM, de Gast GC, Goulmy E. Functional expression of minor histocompatibility antigens on peripheral blood dendritic cells and epidermal Langerhans' cells. Transplant Immunol (in press).
23. de Bueger M, Bakker A, Goulmy E. Acquired tolerance for minor histocompatibility antigens after HLA identical bone marrow transplantation. Int Immunol 1992;4:53-7.
24. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989;4:221-8.
25. Ramsay NKC, Kersey JH, Robison LL, et al. A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 1982;306:392-7.
26. Vossen JM, Heidt PJ. Gnotobiotic measures for the prevention of acute graft-versus-host disease. In. Burakoff SJ, Deeg HJ, Ferrara S, Atkinson K, eds. Graft-versus-host disease: immunology, pathophysiology and treatment. Vol. 12. New York: Marcel Dekker, 1990:403-13.
27. den Haan JMM, Sherman NE, Blokland E, et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995;268:1476-80.
28. Wang W, Meadows LR, den Haan JMM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269:1588-90.